AnandRathi

Concord Biotech Ltd Fundamental Analysis

Last Updated Date: 27 Aug 2026
1,482.10
-60.70 (-3.93%)

Concord Biotech Ltd (Concord Biotech) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹15,505 crore.

Concord Biotech Ltd Overview

Market cap₹15,505 Crs
Volume18,096
Prev. Close₹1,542.80
Year range₹987.05 - ₹1,747.95
Total Value₹2,68,20,081.60
ISININE338H01029

Concord Biotech Ltd Fundamental Analysis

ROCE(TTM)17.41%
P/E Ratio (TTM)54.99
P/B Ratio7.68
Debt to Equity0.00
ROE13.03%
EPS (TTM)27.18
Dividend Yield0.51%
Book Value193.06
Profit Margin25.58%
Operating Margin29.48%

Concord Biotech Ltd Historical Performance

1 Month Return17.91%
6 Month Return21.33%
3 Year Return48.63%
3 Month Return34.81%
1 Year Return-13.07%
5 Year Return-

Concord Biotech Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research